Aizarani, N., Saviano, A., Sagar, Mailly, L., Durand, S., Herman, J.S., Pessaux, P., Baumert, T.F., Grün, D., A human liver cell atlas reveals heterogeneity and epithelial progenitors. Nature 572 (2019), 199–204.
Andreux, P.A., Williams, E.G., Koutnikova, H., Houtkooper, R.H., Champy, M.F., Henry, H., Schoonjans, K., Williams, R.W., Auwerx, J., Systems genetics of metabolism: the use of the BXD murine reference panel for multiscalar integration of traits. Cell 150 (2012), 1287–1299.
Ben-Moshe, S., Shapira, Y., Moor, A.E., Manco, R., Veg, T., Bahar Halpern, K., Itzkovitz, S., Spatial sorting enables comprehensive characterization of liver zonation. Nat. Metab. 1 (2019), 899–911.
Bennett, B.J., Davis, R.C., Civelek, M., Orozco, L., Wu, J., Qi, H., Pan, C., Packard, R.R., Eskin, E., Yan, M., et al. Genetic architecture of atherosclerosis in mice: a systems genetics analysis of common inbred strains. PLoS Genet., 11, 2015, e1005711.
Broman, K.W., Wu, H., Sen, S., Churchill, G.A., R/qtl: QTL mapping in experimental crosses. Bioinformatics 19 (2003), 889–890.
Broman, K.W., Gatti, D.M., Simecek, P., Furlotte, N.A., Prins, P., Sen, Ś., Yandell, B.S., Churchill, G.A., R/qtl2: software for mapping quantitative trait loci with high-dimensional data and multiparent populations. Genetics 211 (2019), 495–502.
Cabrera, D., Arab, J.P., Arrese, M., UDCA, NorUDCA, and TUDCA in liver diseases: a review of their mechanisms of action and clinical applications. Handb. Exp. Pharmacol. 256 (2019), 237–264.
Cani, P.D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A.M., Delzenne, N.M., Burcelin, R., Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57 (2008), 1470–1481.
Chella Krishnan, K., Kurt, Z., Barrere-Cain, R., Sabir, S., Das, A., Floyd, R., Vergnes, L., Zhao, Y., Che, N., Charugundla, S., et al. Integration of multi-omics data from mouse diversity panel highlights mitochondrial dysfunction in non-alcoholic fatty liver disease. Cell Syst. 6 (2018), 103–115.e7.
Chen, L., van den Munckhof, I.C.L., Schraa, K., Ter Horst, R., Koehorst, M., van Faassen, M., van der Ley, C., Doestzada, M., Zhernakova, D.V., Kurilshikov, A., et al. Genetic and microbial associations to plasma and fecal bile acids in obesity relate to plasma lipids and liver fat content. Cell Rep., 33, 2020, 108212.
Chick, J.M., Munger, S.C., Simecek, P., Huttlin, E.L., Choi, K., Gatti, D.M., Raghupathy, N., Svenson, K.L., Churchill, G.A., Gygi, S.P., Defining the consequences of genetic variation on a proteome-wide scale. Nature 534 (2016), 500–505.
Cho, C.S., Xi, J., Si, Y., Park, S.R., Hsu, J.E., Kim, M., Jun, G., Kang, H.M., Lee, J.H., Microscopic examination of spatial transcriptome using Seq-Scope. Cell 184 (2021), 3559–3572.e22.
Crosignani, A., Battezzati, P.M., Setchell, K.D., Invernizzi, P., Covini, G., Zuin, M., Podda, M., Tauroursodeoxycholic acid for treatment of primary biliary cirrhosis. A dose-response study. Dig. Dis. Sci. 41 (1996), 809–815.
Crosignani, A., Budillon, G., Cimino, L., Del Vecchio Blanco, C., Loguercio, C., Ideo, G., Raimondo, G., Stabilini, R., Podda, M., Tauroursodeoxycholic acid for the treatment of HCV-related chronic hepatitis: a multicenter placebo-controlled study. Hepatogastroenterology. 45 (1998), 1624–1629.
David, L.A., Maurice, C.F., Carmody, R.N., Gootenberg, D.B., Button, J.E., Wolfe, B.E., Ling, A.V., Devlin, A.S., Varma, Y., Fischbach, M.A., et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505 (2014), 559–563.
Duysen, E.G., Koentgen, F., Williams, G.R., Timperley, C.M., Schopfer, L.M., Cerasoli, D.M., Lockridge, O., Production of ES1 plasma carboxylesterase knockout mice for toxicity studies. Chem. Res. Toxicol. 24 (2011), 1891–1898.
Elia, A.E., Lalli, S., Monsurrò, M.R., Sagnelli, A., Taiello, A.C., Reggiori, B., La Bella, V., Tedeschi, G., Albanese, A., Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis. Eur. J. Neurol. 23 (2016), 45–52.
Gerloff, T., Stieger, B., Hagenbuch, B., Madon, J., Landmann, L., Roth, J., Hofmann, A.F., Meier, P.J., The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J. Biol. Chem. 273 (1998), 10046–10050.
Gieger, C., Geistlinger, L., Altmaier, E., Hrabé de Angelis, M., Kronenberg, F., Meitinger, T., Mewes, H.W., Wichmann, H.E., Weinberger, K.M., Adamski, J., et al. Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum. PLoS Genet., 4, 2008, e1000282.
Gu, Z., Gu, L., Eils, R., Schlesner, M., Brors, B., circlize implements and enhances circular visualization in R. Bioinformatics 30 (2014), 2811–2812.
Gu, Z., Eils, R., Schlesner, M., Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32 (2016), 2847–2849.
Haeusler, R.A., Pratt-Hyatt, M., Welch, C.L., Klaassen, C.D., Accili, D., Impaired generation of 12-hydroxylated bile acids links hepatic insulin signaling with dyslipidemia. Cell Metab. 15 (2012), 65–74.
Haeusler, R.A., Astiarraga, B., Camastra, S., Accili, D., Ferrannini, E., Human insulin resistance is associated with increased plasma levels of 12α-hydroxylated bile acids. Diabetes 62 (2013), 4184–4191.
Halpern, K.B., Shenhav, R., Matcovitch-Natan, O., Toth, B., Lemze, D., Golan, M., Massasa, E.E., Baydatch, S., Landen, S., Moor, A.E., et al. Single-cell spatial reconstruction reveals global division of labour in the mammalian liver. Nature 542 (2017), 352–356.
Hao, Y., Hao, S., Andersen-Nissen, E., Mauck, W.M. 3rd, Zheng, S., Butler, A., Lee, M.J., Wilk, A.J., Darby, C., Zager, M., et al. Integrated analysis of multimodal single-cell data. Cell 184 (2021), 3573–3587.e29.
Harach, T., Pols, T.W., Nomura, M., Maida, A., Watanabe, M., Auwerx, J., Schoonjans, K., TGR5 potentiates GLP-1 secretion in response to anionic exchange resins. Sci. Rep., 2, 2012, 430.
Häussinger, D., Kordes, C., Mechanisms of tauroursodeoxycholate-mediated hepatoprotection. Dig. Dis. 35 (2017), 224–231.
Hildebrandt, M.A., Hoffmann, C., Sherrill-Mix, S.A., Keilbaugh, S.A., Hamady, M., Chen, Y.Y., Knight, R., Ahima, R.S., Bushman, F., Wu, G.D., High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 137 (2009), 1716–1724.e1–2.
Hui, S.T., Kurt, Z., Tuominen, I., Norheim, F., Davis, R.C., Pan, C., Dirks, D.L., Magyar, C.E., French, S.W., Chella Krishnan, K., et al. The genetic architecture of diet-induced hepatic fibrosis in mice. Hepatology 68 (2018), 2182–2196.
Invernizzi, P., Setchell, K.D., Crosignani, A., Battezzati, P.M., Larghi, A., O'Connell, N.C., Podda, M., Differences in the metabolism and disposition of ursodeoxycholic acid and of its taurine-conjugated species in patients with primary biliary cirrhosis. Hepatology 29 (1999), 320–327.
Irizarry, R.A., Hobbs, B., Collin, F., Beazer-Barclay, Y.D., Antonellis, K.J., Scherf, U., Speed, T.P., Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4 (2003), 249–264.
Jha, P., McDevitt, M.T., Gupta, R., Quiros, P.M., Williams, E.G., Gariani, K., Sleiman, M.B., Diserens, L., Jochem, A., Ulbrich, A., et al. Systems analyses reveal physiological roles and genetic regulators of liver lipid species. Cell Syst. 6 (2018), 722–733.e6.
Jha, P., McDevitt, M.T., Halilbasic, E., Williams, E.G., Quiros, P.M., Gariani, K., Sleiman, M.B., Gupta, R., Ulbrich, A., Jochem, A., et al. Genetic regulation of plasma lipid species and their association with metabolic phenotypes. Cell Syst. 6 (2018), 709–721.e6.
Kaddurah-Daouk, R., Hankemeier, T., Scholl, E.H., Baillie, R., Harms, A., Stage, C., Dalhoff, K.P., Jűrgens, G., Taboureau, O., Nzabonimpa, G.S., et al. Pharmacometabolomics informs about pharmacokinetic profile of methylphenidate. CPT Pharmacometrics Syst. Pharmacol. 7 (2018), 525–533.
Kars, M., Yang, L., Gregor, M.F., Mohammed, B.S., Pietka, T.A., Finck, B.N., Patterson, B.W., Horton, J.D., Mittendorfer, B., Hotamisligil, G.S., Klein, S., Tauroursodeoxycholic acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women. Diabetes 59 (2010), 1899–1905.
Keele, G.R., Zhang, T., Pham, D.T., Vincent, M., Bell, T.A., Hock, P., Shaw, G.D., Paulo, J.A., Munger, S.C., de Villena, P.-M., et al. Regulation of protein abundance in genetically diverse mouse populations. Cell Genomics, 1, 2021, 100003.
Kemis, J.H., Linke, V., Barrett, K.L., Boehm, F.J., Traeger, L.L., Keller, M.P., Rabaglia, M.E., Schueler, K.L., Stapleton, D.S., Gatti, D.M., et al. Genetic determinants of gut microbiota composition and bile acid profiles in mice. PLoS Genet., 15, 2019, e1008073.
Kusaczuk, M., Tauroursodeoxycholate-bile acid with chaperoning activity: molecular and cellular effects and therapeutic perspectives. Cells, 8, 2019, 1471.
Larghi, A., Crosignani, A., Battezzati, P.M., De Valle, G., Allocca, M., Invernizzi, P., Zuin, M., Podda, M., Ursodeoxycholic and tauro-ursodeoxycholic acids for the treatment of primary biliary cirrhosis: a pilot crossover study. Aliment. Pharmacol. Ther. 11 (1997), 409–414.
Li, H., Auwerx, J., Mouse systems genetics as a prelude to precision medicine. Trends Genet. 36 (2020), 259–272.
Li, J., Dawson, P.A., Animal models to study bile acid metabolism. Biochim. Biophys. Acta Mol. Basis Dis. 1865 (2019), 895–911.
Li, H., Wang, X., Rukina, D., Huang, Q., Lin, T., Sorrentino, V., Zhang, H., Bou Sleiman, M., Arends, D., McDaid, A., et al. An integrated systems genetics and omics toolkit to probe gene function. Cell Syst. 6 (2018), 90–102.e4.
Li, H., Rukina, D., David, F.P.A., Li, T.Y., Oh, C.M., Gao, A.W., Katsyuba, E., Bou Sleiman, M., Komljenovic, A., Huang, Q., et al. Identifying gene function and module connections by the integration of multispecies expression compendia. Genome Res. 29 (2019), 2034–2045.
Li-Hawkins, J., Lund, E.G., Turley, S.D., Russell, D.W., Disruption of the oxysterol 7α-hydroxylase gene in mice. J. Biol. Chem. 275 (2000), 16536–16542.
Li-Hawkins, J., Gåfvels, M., Olin, M., Lund, E.G., Andersson, U., Schuster, G., Björkhem, I., Russell, D.W., Eggertsen, G., Cholic acid mediates negative feedback regulation of bile acid synthesis in mice. J. Clin. Invest. 110 (2002), 1191–1200.
Ma, H., Zeng, M., Han, Y., Yan, H., Tang, H., Sheng, J., Hu, H., Cheng, L., Xie, Q., Zhu, Y., et al. A multicenter, randomized, double-blind trial comparing the efficacy and safety of TUDCA and UDCA in Chinese patients with primary biliary cholangitis. Medicine (Baltimore), 95, 2016, e5391.
Marion, S., Desharnais, L., Studer, N., Dong, Y., Notter, M.D., Poudel, S., Menin, L., Janowczyk, A., Hettich, R.L., Hapfelmeier, S., Bernier-Latmani, R., Biogeography of microbial bile acid transformations along the murine gut. J. Lipid Res. 61 (2020), 1450–1463.
Nadeau, J.H., Auwerx, J., The virtuous cycle of human genetics and mouse models in drug discovery. Nat. Rev. Drug Discov. 18 (2019), 255–272.
Norheim, F., Hasin-Brumshtein, Y., Vergnes, L., Chella Krishnan, K., Pan, C., Seldin, M.M., Hui, S.T., Mehrabian, M., Zhou, Z., Gupta, S., et al. Gene-by-sex interactions in mitochondrial functions and cardio-metabolic traits. Cell Metab. 29 (2019), 932–949.e4.
Ozcan, U., Yilmaz, E., Ozcan, L., Furuhashi, M., Vaillancourt, E., Smith, R.O., Görgün, C.Z., Hotamisligil, G.S., Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 313 (2006), 1137–1140.
Pan, X.L., Zhao, L., Li, L., Li, A.H., Ye, J., Yang, L., Xu, K.S., Hou, X.H., Efficacy and safety of tauroursodeoxycholic acid in the treatment of liver cirrhosis: a double-blind randomized controlled trial. J. Huazhong Univ. Sci. Technolog. Med. Sci. 33 (2013), 189–194.
Parker, B.L., Calkin, A.C., Seldin, M.M., Keating, M.F., Tarling, E.J., Yang, P., Moody, S.C., Liu, Y., Zerenturk, E.J., Needham, E.J., et al. An integrative systems genetic analysis of mammalian lipid metabolism. Nature 567 (2019), 187–193.
Perino, A., Schoonjans, K., Metabolic messengers: bile acids. Nat. Metab. 4 (2022), 416–423.
Perino, A., Demagny, H., Velazquez-Villegas, L.A., Schoonjans, K., Molecular physiology of bile acid signaling in health, disease and aging. Physiol. Rev. 101 (2020), 683–731.
Perino, A., Velázquez-Villegas, L.A., Bresciani, N., Sun, Y., Huang, Q., Fénelon, V.S., Castellanos-Jankiewicz, A., Zizzari, P., Bruschetta, G., Jin, S., et al. Central anorexigenic actions of bile acids are mediated by TGR5. Nat. Metab. 3 (2021), 595–603.
Portincasa, P., DiCiaula, A., Palmieri, V., Velardi, A., Van Berge-Henegouwen, G.P., Palasciano, G., Tauroursodeoxycholic acid, ursodeoxycholic acid and gallbladder motility in gallstone patients and healthy subjects. Ital. J. Gastroenterol. 28 (1996), 111–113.
Qin, Y., Wang, Y., Liu, O., Jia, L., Fang, W., Du, J., Wei, Y., Tauroursodeoxycholic acid attenuates angiotensin II induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice by inhibiting endoplasmic reticulum stress. Eur. J. Vasc. Endovasc. Surg. 53 (2017), 337–345.
Redinbo, M.R., Bencharit, S., Potter, P.M., Human carboxylesterase 1: from drug metabolism to drug discovery. Biochem. Soc. Trans. 31 (2003), 620–624.
Rodrigues, C.M., Sola, S., Nan, Z., Castro, R.E., Ribeiro, P.S., Low, W.C., Steer, C.J., Tauroursodeoxycholic acid reduces apoptosis and protects against neurological injury after acute hemorrhagic stroke in rats. Proc. Natl. Acad. Sci. USA 100 (2003), 6087–6092.
Russell, D.W., The enzymes, regulation, and genetics of bile acid synthesis. Annu. Rev. Biochem. 72 (2003), 137–174.
Sasaki, T., Watanabe, Y., Kuboyama, A., Oikawa, A., Shimizu, M., Yamauchi, Y., Sato, R., Muscle-specific TGR5 overexpression improves glucose clearance in glucose-intolerant mice. J. Biol. Chem., 296, 2021, 100131.
Sayin, S.I., Wahlström, A., Felin, J., Jäntti, S., Marschall, H.U., Bamberg, K., Angelin, B., Hyötyläinen, T., Orešič, M., Bäckhed, F., Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 17 (2013), 225–235.
Schaap, F.G., Trauner, M., Jansen, P.L., Bile acid receptors as targets for drug development. Nat. Rev. Gastroenterol. Hepatol. 11 (2014), 55–67.
Selwyn, F.P., Csanaky, I.L., Zhang, Y., Klaassen, C.D., Importance of large intestine in regulating bile acids and glucagon-like peptide-1 in germ-free mice. Drug Metab. Dispos. 43 (2015), 1544–1556.
Setchell, K.D., Rodrigues, C.M., Podda, M., Crosignani, A., Metabolism of orally administered tauroursodeoxycholic acid in patients with primary biliary cirrhosis. Gut 38 (1996), 439–446.
Shin, S.Y., Fauman, E.B., Petersen, A.K., Krumsiek, J., Santos, R., Huang, J., Arnold, M., Erte, I., Forgetta, V., Yang, T.P., et al. An atlas of genetic influences on human blood metabolites. Nat. Genet. 46 (2014), 543–550.
Smallwood, T.L., Gatti, D.M., Quizon, P., Weinstock, G.M., Jung, K.C., Zhao, L., Hua, K., Pomp, D., Bennett, B.J., High-resolution genetic mapping in the diversity outbred mouse population identifies Apobec1 as a candidate gene for atherosclerosis. G3 (Bethesda) 4 (2014), 2353–2363.
Sonnenburg, J.L., Bäckhed, F., Diet-microbiota interactions as moderators of human metabolism. Nature 535 (2016), 56–64.
Sorrentino, G., Perino, A., Yildiz, E., El Alam, G., Bou Sleiman, M., Gioiello, A., Pellicciari, R., Schoonjans, K., Bile acids signal via TGR5 to activate intestinal stem cells and epithelial regeneration. Gastroenterology 159 (2020), 956–968.e8.
Thomas, C., Gioiello, A., Noriega, L., Strehle, A., Oury, J., Rizzo, G., Macchiarulo, A., Yamamoto, H., Mataki, C., Pruzanski, M., et al. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab. 10 (2009), 167–177.
Uhlén, M., Fagerberg, L., Hallström, B.M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., et al. Proteomics. Tissue-based map of the human proteome. Science, 347, 2015, 1260419.
Velazquez-Villegas, L.A., Perino, A., Lemos, V., Zietak, M., Nomura, M., Pols, T.W.H., Schoonjans, K., TGR5 signalling promotes mitochondrial fission and beige remodelling of white adipose tissue. Nat. Commun., 9, 2018, 245.
Visscher, P.M., Wray, N.R., Zhang, Q., Sklar, P., McCarthy, M.I., Brown, M.A., Yang, J., 10 years of GWAS discovery: biology, function, and translation. Am. J. Hum. Genet. 101 (2017), 5–22.
Wahlström, A., Sayin, S.I., Marschall, H.U., Bäckhed, F., Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab. 24 (2016), 41–50.
Wang, L., Jiao, Y., Cao, Y., Liu, G., Wang, Y., Gu, W., Limitation of number of strains and persistence of false positive loci in QTL mapping using recombinant inbred strains. PLoS One, 9, 2014, e102307.
Watanabe, M., Houten, S.M., Mataki, C., Christoffolete, M.A., Kim, B.W., Sato, H., Messaddeq, N., Harney, J.W., Ezaki, O., Kodama, T., et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 439 (2006), 484–489.
Wickham, H., ggplot2: Elegant Graphics for Data Analysis, 2016, Springer-Verlag.
Williams, E.G., Wu, Y., Jha, P., Dubuis, S., Blattmann, P., Argmann, C.A., Houten, S.M., Amariuta, T., Wolski, W., Zamboni, N., et al. Systems proteomics of liver mitochondria function. Science, 352, 2016, aad0189.
Xia, S.W., Wang, Z.M., Sun, S.M., Su, Y., Li, Z.H., Shao, J.J., Tan, S.Z., Chen, A.P., Wang, S.J., Zhang, Z.L., et al. Endoplasmic reticulum stress and protein degradation in chronic liver disease. Pharmacol. Res., 161, 2020, 105218.
Zangerolamo, L., Vettorazzi, J.F., Rosa, L.R.O., Carneiro, E.M., Barbosa, H.C.L., The bile acid TUDCA and neurodegenerative disorders: an overview. Life Sci., 272, 2021, 119252.
